AC Immune, a Swiss clinical stage biopharmaceutical company pioneering in precision medicine for neurodegenerative diseases listed on the Nasdaq completed an underwritten offering of 14.3 million of its common shares at a price of USD 3.50 per
Tags :Daniel Junginger
In early October UBS has published the Base Prospectus for the establishment of its CHF 20 bn program for the issuance of Covered Bonds issued by UBS Switzerland and guaranteed by UBS Hypotheken Schweiz. The
Homburger acted as Swiss counsel to AtlasEdge, a renowned pan-European Edge data centre provider, on a scalable EUR 725 m loan financing. The financing was underwritten by mandated lead arranger ING Bank, as well as ABN
Credit Suisse Switzerland issued an aggregate of EUR 750 million of covered bonds. The new series, EUR 750 m Fixed-Rate Covered Bonds due 2026, has been Credit Suisse Switzerland’s inaugural EUR covered bonds issuance. The covered bonds
Homburger has advised Credit Suisse and UBS Switzerland in connection with the financing of Farner Consulting in support of its international buy-&-build strategy. Farner Consulting, together with its subsidiaries Rod and DU DA,
In November 2021, AMAG Leasing, a subsidiary of AMAG Group, established its CHF 1.5 bn Auto Covered Bond Programme irrevocably guaranteed as to payments of interest and principal by AMAG Leasing Auto Covered Bond. Recently, on November 3, 2022,
Homburger acted as counsel to Citibank Europe plc, UK Branch, in its capacity as Agent, Citibank, N.A., London Branch, in its capacity as Bookrunner or Mandated Lead Arranger and UBS Switzerland, in its capacity
Sika has signed a definitive agreement to acquire MBCC Group, the former BASF Construction Chemicals, from an affiliate of Lone Star Funds, a global private equity firm, for a consideration of CHF 5.5 billion (EUR 5.2 billion).
Unigestion, an independent, specialist asset management company providing tailored solutions for investors worldwide, has invested in Home Instead, a provider of home care services, predominantly for the elderly.Home Instead is the exclusive franchisee of
HBM Healthcare Investments successfully issued CHF 100 million 1.125 per cent Bonds due 2027. The bonds will be admitted for trading and listing on the SIX Swiss Exchange. The advisors Homburger acted as counsel to HBM Healthcare
